Glycated fetal calf serum affects the viability of an insulin-secreting cell line in vitro

Metabolism: Clinical and Experimental

Volumn 57, Issue 2, 2008, Pages 163-169

  Luciano Viviani, Giorgio ^a   Puddu, Alessandra ^a   Sacchi, Gianni ^a   Garuti, Anna ^a   Storace, Daniela ^a   Durante, Arianna ^a   Monacelli, Fiammetta ^a   Odetti, Patrizio ^a  

^a Gerontology and Geriatrics ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; GLUCOSE; PENTOSIDINE; RIBOSE; THIOBARBITURIC ACID DERIVATIVE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL DEATH; CELL GROWTH; CELL PROLIFERATION; CELL STIMULATION; CELL VIABILITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FETAL CALF SERUM; GLYCATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; INCUBATION TIME; INSULIN RELEASE; NONHUMAN; OXIDATIVE STRESS; PANCREAS ISLET CELL; PRIORITY JOURNAL;

AGE FACTORS; ANIMALS; APOPTOSIS; ARGININE; CATTLE; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; INSULIN; INSULIN-SECRETING CELLS; LYSINE; OXIDATIVE STRESS; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 38049144209     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2007.08.020     Document Type: Article

References (46)

1. Wild S., Roglic G., Green A., Sicree R., and King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27 (2004) 1047-1053
2. Stumvoll M., Goldstein B.J., and van Haeften T.W. Type 2 diabetes: principles of pathogenesis and therapy. Lancet 365 (2005) 1333-1346
3. Weyer C., Bogardus C., Mott D.M., and Pratley R.E. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 104 (1999) 787-794
4. Boden G., and Shulman G.I. Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest 32 Suppl 3 (2002) S14-S23
5. Lin X., Taguchi A., Park S., et al. Dysregulation of insulin receptor substrate 2 in beta cells and brain causes obesity and diabetes. J Clin Invest 114 (2004) 908-916
6. Muse E.D., Obici S., Bhanot S., et al. Role of resistin in diet-induced hepatic insulin resistance. J Clin Invest 114 (2004) 232-239
7. Patti M.E., Butte A.J., Crunkhorn S., et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc Natl Acad Sci U S A 100 (2003) 8466-8471
8. Suzuki R., Tobe K., Aoyama M., et al. Both insulin signaling defects in the liver and obesity contribute to insulin resistance and cause diabetes in Irs2(-/-) mice. J Biol Chem 279 (2004) 25039-25049
9. Robertson R.P., Harmon J., Tran P.O., and Poitout V. Beta cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. Diabetes 53 Suppl 1 (2004) s119-s124
10. Hull R.L., Westermark G.T., Westermark P., and Kahn S.E. Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes. J Clin Endocrinol Metab 89 (2004) 3629-3643
11. Boden G., and Shulman G.I. Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and β-cell dysfunction. Eur J Clin Invest 32 Suppl 3 (2002) s14-s23
12. Wu L., Nicholson W., Knobel S.M., et al. Oxidative stress is a mediator of glucose toxicity in insulin-secreting pancreatic islet cell lines. J Biol Chem 279 (2004) 12126-12134
13. Kharroubi I., Ladriere L., Cardozo A.K., Dogusan Z., Cnop M., and Eizirik D.L. Free fatty acids and cytokines induce pancreatic beta-cell apoptosis by different mechanisms: role of nuclear factor-kappaB and endoplasmic reticulum stress. Endocrinology 145 (2004) 5087-5096
14. Harmon J.S., Stein R., and Robertson R.P. Oxidative stress-mediated, post-translational loss of MafA protein as a contributing mechanism to loss of insulin gene expression in glucotoxic beta cells. J Biol Chem 280 (2005) 11107-11113
15. Matsuoka T., Kajimoto Y., Watada H., et al. Glycation-dependent, reactive oxygen species-mediated suppression of the insulin gene promoter activity in HIT cells. J Clin Invest 99 (1997) 144-150
16. Tanaka Y., Gleason C.E., Tran P.O.T., Harmon J.S., and Robertson R.P. Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidants. Proc Natl Acad Sci U S A 96 (1999) 10857-10862
17. Brownlee M. A radical explanation for glucose-induced beta-cell dysfunction. J Clin Invest 112 (2003) 1788-1790
18. Tajiri Y., and Grill V. Aminoguanidine exerts a beta-cell function-preserving effect in high glucose-cultured beta-cells (INS-1). Int J Exp Diabetes Res 1 (2000) 111-119
19. Kajimoto Y., Matsuoka T., Kaneto H., et al. Induction of glycation suppresses glucokinase gene expression in HIT15 cells. Diabetologia 42 (1999) 1417-1424
20. Yan S.D., Schmidt A.M., Anderson G.M., et al. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem 269 (1994) 9889-9897
21. Ihara Y., Toyokuni S., Uchida K., et al. Hyperglycemia causes oxidative stress in pancreatic beta-cells of GK model of type 2 diabetes. Diabetes 48 (1999) 927-932
22. Odetti P., Fogarty J., Sell D.R., and Monnier V.M. Chromatographic quantitation of plasma and red blood cell pentosidine in diabetic and uraemic subjects. Diabetes 41 (1992) 153-159
23. Wong S.H., Knight J.A., Hopfer S.M., Zaharia O., Leach Jr. C.N., and Sunderman Jr. F.W. Lipoperoxides in plasma as measured by liquid-chromatographic separation of malondialdehyde-thiobarbituric acid adduct. Clin Chem 33 (1987) 214-220
24. Kriska A.M., Saremi A., Hanson R.L., et al. Physical activity, obesity, and the incidence of type 2 diabetes in a high-risk population. Am J Epidemiol 158 (2003) 669-675
25. Hu G., Lindstrom J., Valle T.T., et al. Physical activity, body mass index, and risk of type 2 diabetes in patients with normal or impaired glucose regulation. Arch Intern Med 164 (2004) 892-896
26. Wolever T.M., and Mehling C. Long-term effect of varying the source or amount of dietary carbohydrate on postprandial plasma glucose, insulin, triacylglycerol, and free fatty acid concentrations in subjects with impaired glucose tolerance. Am J Clin Nutr 77 (2003) 612-621
27. O'Rahilly S., Barroso I., and Wareham N.J. Genetic factors in type 2 diabetes: the end of the beginning?. Science 307 (2005) 370-373
28. Donath M.Y., Gross D.J., Cerasi E., and Kaiser N. Hyperglycemia-induced β-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes. Diabetes 48 (1999) 738-744
29. Monnier V.M., Sell D.R., Nagaraj R.H., et al. Maillard reaction-mediated molecular damage to extracellular matrix and other tissue proteins in diabetes, aging and uremia. Diabetes 41 Suppl 2 (1992) s36-s41
30. Sell D.R., Lane M.A., Johnson W.A., et al. Longevity and the genetic determination of collagen glycoxidation kinetics in mammalian senescence. Proc Natl Acad Sci U S A 93 (1996) 485-490
31. Robertson P.R., Harmon J., Tran P.O., et al. Glucose toxicity in beta-cells: type-2 diabetes, good radicals gone bad, and the glutathione connection. Diabetes 52 (2003) 581-587
32. Bierhaus A., Chevion S., Chevion M., et al. Advanced glycation end product-induced activation of NF-kappaB is suppressed by alpha-lipoic acid in cultured endothelial cells. Diabetes 46 (1997) 1481-1490
33. Nitti M., d'Abramo C., Traverso N., et al. Central role of PKC delta in glycoxidation-dependent apoptosis of human neurons. Free Radic Biol Med 38 (2005) 846-856
34. Min C., Kang E., Yu S.-H., Shinn S.-H., and Kim Y.-S. Advanced glycation end products induce apoptosis and procoagulant activity in cultured human umbilical vein endothelial cells. Diabetes Res Clin Pract 46 (1999) 197-202
35. Matsunaga T., Iguchi K., Koyama I., et al. Glycated high-density lipoprotein induces apoptosis of endothelial cells via a mitochondrial dysfunction. Biochem Biophys Res Commun 28 (2001) 714-720
36. Cohen G., Rudnicki M., Walter F., Niwa T., and Horl W.H. Glucose-modified proteins modulate essential functions and apoptosis of polymorphonuclear leukocytes. J Am Soc Nephrol 12 (2001) 1264-1271
37. Takeuchi M., Bucala R., Suzuki T., et al. Neurotoxicity of advanced glycation end-products for cultured cortical neurons. J Neuropathol Exp Neurol 59 (2000) 1094-1105
38. Kasper M., Roehlecke C., Witt M., et al. Induction of apoptosis by glyoxal in human embryonic lung epithelial cell line L132. Am J Respir Cell Mol Biol 23 (2000) 485-491
39. Schmidt A.M., Hori O., Brett J., Yan S.D., Wautier J.L., and Stern D. Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. Arterioscler Thromb 14 (1994) 1521-1528
40. Shanmugam N., Todorov I.T., Nair I., Omori K., Reddy M.A., and Natarajan R. Increased expression of cyclooxygenase-2 in human pancreatic islets treated with high glucose or ligands of the advanced glycation end product-specific receptor (AGER), and in islets from diabetic mice. Diabetologia 49 (2006) 100-107
41. Kaneto H., Fujii J., Myint T., et al. Reducing sugars trigger oxidative modification and apoptosis in pancreatic beta-cells by provoking oxidative stress through the glycation reaction. Biochem J 320 (1996) 855-863
42. Kooptiwut S., Kebede M., Zraika S., et al. High glucose-induced impairment in insulin secretion is associated with reduction in islet glucokinase in a mouse model of susceptibility to islet dysfunction. J Mol Endocrinol 35 (2005) 39-48
43. Goh T.T., Mason T.M., Gupta, et al. Lipid-induced beta-cell dysfunction in vivo in models of progressive beta-cell failure. Am J Physiol Endocrinol Metab 292 2 (2006) E549-E560
44. Robertson R.P., Harmon J., Tran P.O., et al. Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. Diabetes 53 Suppl 1 (2004) S119-S124
45. Baynes J.W., and Thorpe S.R. Glycoxidation and lipoxidation in atherogenesis. Free Radic Biol Med 28 12 (2000) 1708-1716
46. Evans J.L., Maddux B.A., and Goldfine I.D. The molecular basis for oxidative stress-induced insulin resistances. Antioxid Redox Signal 7 (2005) 1040-1052